Screener
Lantern Pharma LTRN Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.57Miss by $0.19
EPS estimate-$0.38
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Lantern Pharma report Q2 2026 earnings?
- Lantern Pharma (LTRN) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Lantern Pharma's Q2 2026 revenue and EPS?
- Lantern Pharma reported eps of $-0.57 for Q2 2026.
- Did Lantern Pharma beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.38 by $0.19.
- How did Lantern Pharma's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 42.5% from $-0.40.
- Where can I find Lantern Pharma's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-037979) and the 10-Q periodic report (0001493152-26-037971) directly on SEC EDGAR. The filing index links above go to sec.gov.
